CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Titre original de l'avis
Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
45 / 100
Facteurs de risque
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Moderate opportunityFaits clés
- EUR 5.6M estimated value
- Supplies contract
- 1 lot
- Supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for Inflammatory Bowel Disease (IBD)
- Framework contract; no quantities or minimum spend specified
Afficher le résumé complet
This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.
Risques
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Technical
- Must supply pharmaceutical products classified under CPV 33693100
Administrative
- Electronic submission via eTenders Malta portal
- Tender must be submitted in English
Les exigences peuvent être incomplètes.
Acheteur
Localisation
Floriana, MLT
Site web
Profil acheteur
Identifiant
MT25645419
Activité
General public services
Lots (1)
LOT-0001
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.
EUR 5.6M
Valeur estimée
Localisation
Catégorie
Date limite
Détails des critères
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Note sur la valeur
Afficher les données TED originales
Description TED originale
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Détails de la procédure
- Date de publication
- 10 Jun 2026
- Langues
- English
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 400302-2026
Documents (2)
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
45 / 100
Facteurs de risque
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications